Idiopathic hirsutism: An uncommon cause of hirsutism in Alabama

Fertility and Sterility

Volumn 70, Issue 2, 1998, Pages 274-278

  Azziz, Ricardo ^b   Waggoner, Wende T ^b   Ochoa, Tatiana ^a,b   Knochenhauer, Eric S ^b   Boots, Larry R ^b  

^a Min de Salud Publica del Ecuador   (Ecuador)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Androgens; Hirsutism; Ovulatory dysfunction; Polycystic ovary syndrome

Indexed keywords

HYDROXYPROGESTERONE; PRASTERONE SULFATE; PROGESTERONE; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIRSUTISM; HUMAN; MENSTRUAL CYCLE; OVARY POLYCYSTIC DISEASE; OVULATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; UNITED STATES;

ADOLESCENT; ADULT; ALABAMA; ALGORITHMS; ANOVULATION; CASE-CONTROL STUDIES; FEMALE; HIRSUTISM; HUMANS; PREVALENCE; PROSPECTIVE STUDIES;

EID: 0032145678     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00141-1     Document Type: Article

References (27)

1. 1. Mehta A, Matwijiw I, Taylor PJ, Salamon EA, Kredentser JV, Faiman C. Should androgen levels be measured in hirsute women with normal menstrual cycles? Int J Fertil 1992;37:354-7.
2. 2. Jahanfar S, Eden JA. Idiopathic hirsutism or polycystic ovary syndrome? Aust NZ J Obstet Gynaecol 1993;33:414-6.
3. 3. O'Driscoll JB, Mamtora H, Higginson J, Pollock A, Kane J, Anderson DC. A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clin Endocrinol (Oxf) 1994;41:231-6.
4. 4. Raj SG, Talbert LM. Polycystic ovarian disease. Obstet Gynecol Annu 1984;13:261-73.
5. 5. Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986;293: 355-9.
6. 6. Azziz R, Dewailly D, Owerbach D. Non-classic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 1994;78:810-5.
7. 7. Mowszowicz I, Melanitou E, Doukani A, Wright F, Kuttenn F, Mauvais-Jarvis P. Androgen binding capacity and 5α-reductase activity in pubic skin fibroblasts from hirsute patients. J Clin Endocrinol Metab 1983;56:1209-13.
8. 8. Serafini P, Lobo RA. Increased 5α reductase activity in idiopathic hirsutism. Fertil Steril 1985;43:74-8.
9. 9. Couzinet B, Pholsena M, Young J, Schaison G. The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism. Clin Endocrinol (Oxf) 1993;39:157-62.
10. 10. Tolino A, Petrone A, Sarnacchiaro F, Cirillo D, Ronsini S, Lombardi G, et al. Finasteride in the treatment of hirsutism: new therapeutic perspectives. Fertil Steril 1996;66:61-5.
11. 11. Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, Merriam GR, editors. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications, 1992:377-84.
12. 12. Azziz R, Zacur HA. 21-hydroxylase deficiency in female hyperandrogenism: screening and diagnosis. J Clin Endocrinol Metab 1989;69: 577-84.
13. 13. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: Implications, etiology, and management. Am J Obstet Gynecol 1981;140:815-30.
14. 14. Knochenhauer ES, Kahsar-Miller MD, Boots LR, Key TJ, Azziz R. Prevalence of hirsutism among unselected Black and Caucasian women in the southeastern United States (U.S.) [abstract P1-357]. Program and abstracts of the 79th Annual Meeting of the Endocrine Society. Minneapolis, (MN): The Endocrine Society, 1997:224.
15. 15. Bardin WC, Lipsett MB. Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism or polycystic ovaries. J Clin Invest 1967;46:891-7.
16. 16. Casey JH, Nabarro JDN. Plasma testosterone in idiopathic hirsutism, and the changes produced by adrenal and ovarian stimulation and suppression. J Clin Endocrinol 1967;27:1431-5.
17. 17. Thomas JP, Oake RJ. Androgen metabolism in the skin of hirsute women. J Clin Endocrinol Metab 1974;38:19-22.
18. 18. Kirschner M, Zucker R, Jespersen D. Idiopathic hirsutism - an ovarian abnormality. N Engl J Med 1976;294:637-41.
19. 19. Ettinger B, Goldfield EB, Burrill KC, Von Werder K, Forsham PH. Plasma testosterone stimulation-suppression dynamics in hirsute women. Am J Med 1973;54:195-200.
20. 20. Pugeat M, Forest MG, Nisula BC, Corniau J, De Peretti E, Tourniaire J. Evidence of excessive androgen secretion by both the ovary and the adrenal in patients with idiopathic hirsutism. Obstet Gynecol 1982;59: 46-51.
21. 21. McKenna TJ, Miller RB, Liddle GW. Plasma pregnenolone and 17-OH pregnenolone in patients with adrenal tumors, ACTH excess, or idiopathic hirsutism. J Clin Endocrinol Metab 1977;44:231-6.
22. 22. Rittmaster RS, Thompson DL. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. J Clin Endocrinol Metab 1990;70:1096-1102.
23. 23. Carmina E. Prevalence of idiopathic hirsutism [abstract no. P-286]. Program and abstracts of the 53rd Annual Meeting of the American Society for Reproductive Medicine. Cincinnati (OH): American Society for Reproductive Medicine, 1997:S229.
24. 24. Boots LR, Potter S, Potter HD, Azziz R. Measurement of total serum testosterone level using commercial kits: high degree of variability and inaccuracy. Fertil Steril 1998;69:286-92.
25. 25. Vermeulen A, Stoica T, Verdonck L. The apparent free testosterone concentration, an index of androgenicity. J Clin Endocrinol 1971;33: 759-67.
26. 26. Mathur RS, Moody LO, Landgrebe S, Williamson HO. Plasma androgens and sex hormone binding globulin in the evaluation of hirsute females. Fertil Steril 1981;35:29-35.
27. 27. Carter GD, Holland SM, Alaghband-Zadeh J, Rayman G, Dorrington-Ward P, Wise PH. Investigation of hirsutism: testosterone is not enough. Ann Clin Biochem 1983;20:262-3.